Close Menu

NEW YORK (GenomeWeb) – Foundation Medicine, Roche, and Dian Diagnostics late on Thursday said they plan to collaborate to offer Foundation’s next-generation sequencing tumor profiling tests to patients in China.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.